Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients

Table 2

Patient characteristics: lymphoma patients.

	Poor mobilizers (𝑛=9)	Good mobilizers (𝑛=15)
Age, median (range), years	60 (36–65)	62 (21–75)
Sex,
Male; Female	5; 4	9; 6
Disease stage
II; III; IV	1; 2; 6	4; 0; 10
HD; NHL	1; 8	1; 14
Disease status
CR; PR; Relapse	6; 2; 1	11; 4; 0
Median no. prior treatment regimens (range)	2 (1–3)	2 (1–3)
Prior RT	6*	5
Median time from diagnosis (range), days	730 (376–1327)	1350 (72–6603)
BM involvement	2	0

*One patient had radiation therapy (RT) during childhood.
Note. The results show number of patients in each category unless indicated otherwise.